Vr Adviser, LLC 4 D Molecular Therapeutics, Inc. Transaction History
Vr Adviser, LLC
- $966 Million
- Q3 2024
A detailed history of Vr Adviser, LLC transactions in 4 D Molecular Therapeutics, Inc. stock. As of the latest transaction made, Vr Adviser, LLC holds 4,400,000 shares of FDMT stock, worth $25.6 Million. This represents 4.93% of its overall portfolio holdings.
Number of Shares
4,400,000
Previous 4,400,000
-0.0%
Holding current value
$25.6 Million
Previous $92.4 Million
48.5%
% of portfolio
4.93%
Previous 10.13%
Shares
3 transactions
Others Institutions Holding FDMT
# of Institutions
144Shares Held
57.7MCall Options Held
137KPut Options Held
111K-
Bvf Inc San Francisco, CA7.38MShares$42.9 Million2.54% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.1MShares$29.6 Million0.77% of portfolio
-
Black Rock Inc. New York, NY4.9MShares$28.5 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.1MShares$23.8 Million1.63% of portfolio
-
Goldman Sachs Group Inc New York, NY3.59MShares$20.9 Million0.01% of portfolio
About 4D Molecular Therapeutics, Inc.
- Ticker FDMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 32,382,400
- Market Cap $188M
- Description
- 4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...